Synchronous manifestation is common, however, at present, it is unclear whether telmisartan partially activates PPARγ1 in human colon cancer cells and whether its partial agonism is sufficient for inhibiting proliferation and stimulating apoptosis in a significant manner. Here, PPARG is linked to malignant colon neoplasm.